Literature DB >> 23878790

Application of response surface methodology in development of sirolimus liposomes prepared by thin film hydration technique.

Saeed Ghanbarzadeh1, Hadi Valizadeh, Parvin Zakeri-Milani.   

Abstract

Introduction : The present investigation was aimed to optimize the formulating process of sirolimus liposomes by thin film hydration method. Methods : In this study, a 3(2) factorial design method was used to investigate the influence of two independent variables in the preparation of sirolimus liposomes. The dipalmitoylphosphatidylcholine (DPPC) /Cholesterol (Chol) and dioleoyl phosphoethanolamine(DOPE) /DPPC molar ratios were selected as the independent variables. Particle size (PS) and Encapsulation Efficiency (EE %) were selected as the dependent variables. To separate the un-encapsulated drug, dialysis method was used. Drug analysis was performed with a validated RP-HPLC method. Results : Using response surface methodology and based on the coefficient values obtained for independent variables in the regression equations, it was clear that the DPPC/Chol molar ratio was the major contributing variable in particle size and EE %. The use of a statistical approach allowed us to see individual and/or interaction effects of influencing parameters in order to obtain liposomes with desired properties and to determine the optimum experimental conditions that lead to the enhancement of characteristics. In the prediction of PS and EE % values, the average percent errors are found to be as 3.59 and 4.09%. This value is sufficiently low to confirm the high predictive power of model. Conclusion : Experimental results show that the observed responses were in close agreement with the predicted values and this demonstrates the reliability of the optimization procedure in prediction of PS and EE % in sirolimus liposomes preparation.

Entities:  

Keywords:  Central Composite Design; Liposome; Response Surface Methodology; Sirolimus

Year:  2013        PMID: 23878790      PMCID: PMC3713873          DOI: 10.5681/bi.2013.016

Source DB:  PubMed          Journal:  Bioimpacts        ISSN: 2228-5652


  42 in total

1.  Experimental design for in vitro skin penetration study of liposomal superoxide dismutase.

Authors:  Edith Braun; Andreas Wagner; Eckhard Fürnschlief; Hermann Katinger; Karola Vorauer-Uhl
Journal:  J Pharm Biomed Anal       Date:  2005-10-25       Impact factor: 3.935

2.  Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions.

Authors:  Sweta Modi; Tian-Xiang Xiang; Bradley D Anderson
Journal:  J Control Release       Date:  2012-07-16       Impact factor: 9.776

3.  Countervailing effects of rapamycin (sirolimus) on nuclear factor-kappa B activities in neointimal and medial smooth muscle cells.

Authors:  Wolfgang Dichtl; Eva-Maria Stocker; Klaudia Mistlberger; Paul Debbage; Zhong-qun Yan; Hannes F Alber; Matthias Frick; Jozef Dulak; Otmar Pachinger; Franz Weidinger
Journal:  Atherosclerosis       Date:  2005-09-23       Impact factor: 5.162

4.  Studies on liposome-encapsulated heparin.

Authors:  T D Kim; M Sakon; T Kawasaki; J Kambayashi; T Ohshiro; T Mori
Journal:  Thromb Res       Date:  1986-09-15       Impact factor: 3.944

5.  Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics.

Authors:  Géraldine Piel; Marie Piette; Valery Barillaro; Delphine Castagne; Brigitte Evrard; Luc Delattre
Journal:  Int J Pharm       Date:  2006-02-07       Impact factor: 5.875

6.  Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry.

Authors:  Francesco Liistro; Massimo Fineschi; Paolo Angioli; Giuseppe Sinicropi; Giovanni Falsini; Tommaso Gori; Kenneth Ducci; Achille Bravi; Leonardo Bolognese
Journal:  J Am Coll Cardiol       Date:  2006-06-23       Impact factor: 24.094

7.  Liposome-entrapped [125I]anti-tetanus immunoglobulin G: evidence for entry into spinal cord neurons of the rat.

Authors:  B Niggemann; G Erdmann; H H Wellhöner
Journal:  Neurosci Lett       Date:  1984-10-12       Impact factor: 3.046

8.  Improved formulation of liposome-encapsulated hemoglobin with an anionic non-phospholipid.

Authors:  Hrushikesh Agashe; Pallavi Lagisetty; Shanjana Awasthi; Vibhudutta Awasthi
Journal:  Colloids Surf B Biointerfaces       Date:  2009-10-14       Impact factor: 5.268

9.  pH-Sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity.

Authors:  Eiji Yuba; Chie Kojima; Atsushi Harada; Shinobu Watarai; Kenji Kono
Journal:  Biomaterials       Date:  2009-10-21       Impact factor: 12.479

10.  Encapsulation, with high efficiency, of radioactive metal ions in liposomes.

Authors:  K J Hwang; J E Merriam; P L Beaumier; K F Luk
Journal:  Biochim Biophys Acta       Date:  1982-05-05
View more
  13 in total

1.  Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease.

Authors:  Mónica Anayántzin Linares-Alba; Magda Berenice Gómez-Guajardo; Joice Furtado Fonzar; Dennis E Brooks; Gustavo Adolfo García-Sánchez; Maria Josefa Bernad-Bernad
Journal:  J Ocul Pharmacol Ther       Date:  2015-10-15       Impact factor: 2.671

2.  Development and physicochemical characterization of sirolimus solid dispersions prepared by solvent evaporation method.

Authors:  Shahram Emami; Hadi Valizadeh; Ziba Islambulchilar; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2014-08-10

3.  Encapsulating an Immunosuppressant Enhances Tolerance Induction by Siglec-Engaging Tolerogenic Liposomes.

Authors:  Lijuan Pang; Matthew S Macauley; Britni M Arlian; Corwin M Nycholat; James C Paulson
Journal:  Chembiochem       Date:  2017-04-04       Impact factor: 3.164

4.  Pi-stacking Enhances Stability, Scalability of Formation, Control over Flexibility and Circulation Time of Polymeric Filaments.

Authors:  Sophia Li; Sharan Bobbala; Michael P Vincent; Mallika Modak; Yugang Liu; Evan A Scott
Journal:  Adv Nanobiomed Res       Date:  2021-08-05

5.  Nanoethosomes for Dermal Delivery of Lidocaine.

Authors:  Soraya Babaie; Saeed Ghanbarzadeh; Soodabeh Davaran; Maryam Kouhsoltani; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2015-11-30

6.  Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route.

Authors:  Pratik Upadhyay; Jatin Trivedi; Kilambi Pundarikakshudu; Navin Sheth
Journal:  Saudi Pharm J       Date:  2016-08-05       Impact factor: 4.330

7.  Filgrastim (G-CSF) loaded liposomes: mathematical modeling and optimization of encapsulation efficiency and particle size.

Authors:  Farhad Kiafar; Mohammad Reza Siahi Shadbad; Hadi Valizadeh
Journal:  Bioimpacts       Date:  2016-12-29

8.  pH-sensitive, polymer modified, plasma stable niosomes: promising carriers for anti-cancer drugs.

Authors:  Dena Tila; Seyede Narjes Yazdani-Arazi; Saeed Ghanbarzadeh; Sanam Arami; Zhaleh Pourmoazzen
Journal:  EXCLI J       Date:  2015-01-06       Impact factor: 4.068

Review 9.  Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.

Authors:  Bruno Fonseca-Santos; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2015-08-04

10.  Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach.

Authors:  Lucia Ruxandra Tefas; Bianca Sylvester; Ioan Tomuta; Alina Sesarman; Emilia Licarete; Manuela Banciu; Alina Porfire
Journal:  Drug Des Devel Ther       Date:  2017-05-25       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.